Table II.
Result of sensitivity analysis
| Outcome | Effect size | Heterogeneity | Sensitivity analysis | ||||
|---|---|---|---|---|---|---|---|
| I2 (%) | P | Excluding the largest | Excluding the smallest | Excluding the earliest | Excluding studies with the most contradictory results | ||
| PPG (mg/dl) | 0.06 (−0.14-0.26) | 0 | 0.900 | 0.13 (−0.10-0.35) | 0.03 (−0.17-0.23) | 0.05 (−0.17-0.27) | 0.09 (−0.11-0.30) |
| FPG (mg/dl) | 0.48 (0.27-0.70) | 61 | 0.001 | 0.44 (0.20-0.69) | 0.49 (0.28-0.71) | 0.54 (0.32-0.76) | None |
| HbA1C (%) | 0.13 (−0.04-0.30) | 71 | 0.001 | 0.05 (−0.07-0.17) | 0.13 (−0.04-0.30) | 0.14 (−0.03-0.32) | 0.16 (−0.01-0.32) |
| BMI | 0.09 (−0.00-0.18) | 0 | 0.810 | 0.04 (−0.07-0.14) | 0.08 (−0.01-0.18) | 0.09 (−0.00-0.18) | 0.04 (−0.07-0.14) |
| Fructosamine | −0.08 (−0.24-0.08) | 65 | 0.001 | −0.09 (−0.27-0.09) | −0.08 (−0.25-0.09) | −0.03 (−0.27-0.22) | −0.05 (−0.21-0.11) |
HbA1c, glycated haemoglobin; TG, triglyceride; BMI, body mass index; PPG, post-prandial plasma glucose; FPG, fasting plasma glucose